ARCOS Retail Drug Summary Reports
REPORTING PERIOD - 2011
Automated Reports and Consolidated Ordering System (ARCOS) is a data collection system in which manufacturers and distributors report their controlled substances transactions to the Drug Enforcement Administration (DEA). ARCOS provides an acquisition/distribution transactional records of applicable activities to the DEA involving certain controlled substances, in accordance with Title 21, United States Code, Section 827(d)(1), and Title 21, Code of Federal Regulations, Section 1304.33. This information is collected and compiled by DEA in accordance with law for determining quota, distribution trends, internal audits, and other analyses.
Recipients should be aware, prior to use, analysis, studies, or publication of ARCOS data, the information contained in ARCOS generated reports are complete and accurate as to what was provided by DEA registrants to ARCOS in accordance with reporting requirements. This information is susceptible to future updates and corrections, without notice, as new information is obtained. DEA assumes no liability for analysis, conclusions or policy decisions of third parties based on internal interpretation of provided data.
This section provides total drug amounts (in grams) distributed to retail registrants in each state, by zip code.
This section reflects the total drug quantity distributed to retail registrants in each state, by quarter.
This section reflects each state’s drug consumption in terms of grams per 100K population, by quarter.
This section reflects each state’s cumulative Consumption in grams per 100K population. For each drug, the states are listed in ranking order.
This section gives the average purchase of each drug, for each business activity, in each state.
This section gives the average purchase of each drug, for each business activity within the entire United States.